Urgent

Substance-induced psychosis vs primary psychosis (differentiation)

Substance psychosis · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Distinguishing a substance-induced psychotic disorder from a primary psychotic illness guides prognosis and management. Substance-induced psychosis typically resolves with abstinence over days to weeks, but a substantial proportion (especially with cannabis/stimulants) later convert to a primary psychotic disorder, so follow-up is essential.

Red flags

  • Fever, reduced consciousness or focal signs (encephalitis/organic)
  • Persisting psychosis despite abstinence (suggests primary disorder)
  • Command hallucinations or high-risk behaviour
  • Suicidal or homicidal ideation
  • First presentation at an atypical age

Assessment

Differential diagnosis

  • Substance-induced psychosis (temporal link, resolves with abstinence)
  • First-episode primary psychosis (schizophrenia spectrum)
  • Acute mania with psychotic features
  • Organic delirium or encephalitis (exclude)
  • Drug intoxication/withdrawal state

Investigations

  • Toxicology screen (note NPS/synthetic cannabinoids not detected) and alcohol level
  • Capillary glucose, observations and organic screen
  • Bloods: FBC, U&E, LFTs, CRP, calcium, TFTs
  • ECG before antipsychotics
  • CT head / LP if encephalitis or organic cause suspected (atypical features, fever, reduced consciousness)

Management

  • Establish temporal relationship between substance use and psychotic symptoms
  • Exclude organic causes and intoxication/withdrawal states
  • Provide a safe, low-stimulus environment and de-escalate
  • Manage acute agitation with benzodiazepines; use antipsychotics judiciously
  • Observe for resolution with abstinence (supports substance-induced diagnosis)
  • Avoid committing to a diagnosis of schizophrenia at first presentation
  • Refer to psychiatry/early intervention in psychosis and arrange follow-up
  • Advise on abstinence and refer to substance-misuse services

Drugs & doses

Lorazepam — 1-2 mg PO/IM for agitation, repeat; max 4 mg/24h caution
Haloperidol — 5 mg IM (2.5 mg elderly) with ECG, after benzodiazepine, for severe psychosis
Olanzapine — 10 mg IM (5 mg elderly), not within 1 h of parenteral benzodiazepine
Oral antipsychotic (e.g. olanzapine/risperidone) continued short-term with psychiatric follow-up

Disposition

Admit or arrange urgent psychiatric assessment (MHA if risk and refusing care) for acute psychosis; refer to early intervention in psychosis and substance-misuse services, and ensure follow-up to detect conversion to a primary disorder.

Complications & pitfalls

  • Conversion to a primary psychotic disorder
  • Self-harm or harm to others during the acute episode
  • Missed organic cause (encephalitis)
  • Antipsychotic side-effects (dystonia, QT, NMS)
  • Disengagement and relapse

Exam pearls

  • A clear temporal link to the substance and resolution with abstinence supports substance-induced psychosis
  • A significant minority (notably cannabis/stimulant-related) convert to schizophrenia — follow-up is essential
  • Synthetic cannabinoids and NPS are not detected on routine screens — diagnosis is clinical
  • Do not label a first episode as schizophrenia — refer to early intervention services
  • Persisting symptoms beyond a month of abstinence point away from a purely substance-induced cause

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.